Pause on Johnson & Johnson COVID vaccine in U.S lifted by FDA, use to resume.
Johnson & Johnson's COVID vaccine will be made available to the public again, ending an 11-day pause initiated after a rare blood clotting disorder was associated with the shot.
The Food and Drug Administration and Centers for Disease Control and Prevention determined the benefits of the J&J vaccine outweighed the risks of keeping it off the market. Out of nearly 8 million who received the vaccine, 15 people have developed the condition and three have died.
The two agencies held a joint news conference Friday evening to announce their decision to allow distribution of the J&J vaccine to resume. | Read more